Annual Revenue
$7.01 M
-$1.09 M-13.48%
December 31, 2023
Summary
- As of February 8, 2025, CPHI annual revenue is $7.01 million, with the most recent change of -$1.09 million (-13.48%) on December 31, 2023.
- During the last 3 years, CPHI annual revenue has fallen by -$3.86 million (-35.48%).
- CPHI annual revenue is now -91.36% below its all-time high of $81.17 million, reached on December 31, 2011.
Performance
CPHI Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$1.10 M
+$175.30 K+18.95%
September 30, 2024
Summary
- As of February 8, 2025, CPHI quarterly revenue is $1.10 million, with the most recent change of +$175.30 thousand (+18.95%) on September 30, 2024.
- Over the past year, CPHI quarterly revenue has dropped by -$1.05 million (-48.82%).
- CPHI quarterly revenue is now -95.41% below its all-time high of $23.97 million, reached on December 31, 2010.
Performance
CPHI Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$5.54 M
-$703.30 K-11.26%
September 30, 2024
Summary
- As of February 8, 2025, CPHI TTM revenue is $5.54 million, with the most recent change of -$703.30 thousand (-11.26%) on September 30, 2024.
- Over the past year, CPHI TTM revenue has dropped by -$1.47 million (-20.92%).
- CPHI TTM revenue is now -93.29% below its all-time high of $82.68 million, reached on September 30, 2011.
Performance
CPHI TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CPHI Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.5% | -48.8% | -20.9% |
| 3 y3 years | -35.5% | -31.8% | -31.4% |
| 5 y5 years | -43.1% | -62.5% | -49.0% |
CPHI Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.3% | at low | -62.3% | +18.9% | -42.5% | at low |
| 5 y | 5-year | -35.8% | at low | -70.8% | +18.9% | -51.6% | at low |
| alltime | all time | -91.4% | >+9999.0% | -95.4% | >+9999.0% | -93.3% | >+9999.0% |
China Pharma Holdings Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.10 M(+19.0%) | $5.54 M(-11.3%) |
| Jun 2024 | - | $924.90 K(-32.5%) | $6.25 M(-2.7%) |
| Mar 2024 | - | $1.37 M(-36.3%) | $6.42 M(-8.4%) |
| Dec 2023 | $7.01 M(-13.5%) | $2.15 M(+19.2%) | $7.01 M(-9.9%) |
| Sep 2023 | - | $1.80 M(+64.3%) | $7.78 M(-2.0%) |
| Jun 2023 | - | $1.10 M(-44.0%) | $7.95 M(-6.1%) |
| Mar 2023 | - | $1.96 M(-32.9%) | $8.46 M(+4.4%) |
| Dec 2022 | $8.10 M(-15.9%) | $2.92 M(+48.6%) | $8.10 M(+0.4%) |
| Sep 2022 | - | $1.97 M(+21.9%) | $8.07 M(-0.2%) |
| Jun 2022 | - | $1.61 M(+0.6%) | $8.09 M(-9.0%) |
| Mar 2022 | - | $1.60 M(-44.5%) | $8.89 M(-7.8%) |
| Dec 2021 | $9.64 M(-11.3%) | $2.89 M(+46.0%) | $9.64 M(-0.4%) |
| Sep 2021 | - | $1.98 M(-18.1%) | $9.68 M(-4.2%) |
| Jun 2021 | - | $2.42 M(+2.4%) | $10.11 M(-11.8%) |
| Mar 2021 | - | $2.36 M(-19.5%) | $11.46 M(+5.5%) |
| Dec 2020 | $10.87 M(-0.5%) | $2.93 M(+22.1%) | $10.87 M(-1.1%) |
| Sep 2020 | - | $2.40 M(-36.3%) | $10.98 M(+0.2%) |
| Jun 2020 | - | $3.77 M(+113.8%) | $10.96 M(+12.3%) |
| Mar 2020 | - | $1.76 M(-42.1%) | $9.76 M(-10.7%) |
| Dec 2019 | $10.92 M(-11.4%) | $3.05 M(+28.3%) | $10.92 M(-1.7%) |
| Sep 2019 | - | $2.38 M(-7.5%) | $11.12 M(+0.7%) |
| Jun 2019 | - | $2.57 M(-12.3%) | $11.04 M(-5.2%) |
| Mar 2019 | - | $2.93 M(-9.7%) | $11.64 M(-5.6%) |
| Dec 2018 | $12.33 M(-6.7%) | $3.24 M(+41.1%) | $12.33 M(-4.7%) |
| Sep 2018 | - | $2.30 M(-27.6%) | $12.94 M(-6.3%) |
| Jun 2018 | - | $3.17 M(-12.2%) | $13.80 M(+1.9%) |
| Mar 2018 | - | $3.62 M(-6.0%) | $13.54 M(+2.5%) |
| Dec 2017 | $13.21 M(-15.1%) | $3.85 M(+21.7%) | $13.21 M(-9.7%) |
| Sep 2017 | - | $3.16 M(+8.4%) | $14.63 M(+0.3%) |
| Jun 2017 | - | $2.92 M(-11.2%) | $14.59 M(-4.1%) |
| Mar 2017 | - | $3.29 M(-37.6%) | $15.22 M(-2.3%) |
| Dec 2016 | $15.57 M(-23.5%) | $5.26 M(+68.4%) | $15.57 M(+5.1%) |
| Sep 2016 | - | $3.13 M(-11.8%) | $14.81 M(-8.4%) |
| Jun 2016 | - | $3.54 M(-2.7%) | $16.17 M(-11.7%) |
| Mar 2016 | - | $3.64 M(-19.2%) | $18.30 M(-10.1%) |
| Dec 2015 | $20.35 M(-8.1%) | $4.50 M(+0.5%) | $20.35 M(+6.1%) |
| Sep 2015 | - | $4.48 M(-21.1%) | $19.18 M(-5.4%) |
| Jun 2015 | - | $5.67 M(-0.4%) | $20.27 M(-2.2%) |
| Mar 2015 | - | $5.69 M(+71.0%) | $20.72 M(-6.4%) |
| Dec 2014 | $22.13 M(-32.5%) | $3.33 M(-40.2%) | $22.13 M(-18.7%) |
| Sep 2014 | - | $5.57 M(-9.2%) | $27.22 M(-8.6%) |
| Jun 2014 | - | $6.13 M(-13.7%) | $29.77 M(-6.0%) |
| Mar 2014 | - | $7.11 M(-15.6%) | $31.66 M(-3.5%) |
| Dec 2013 | $32.81 M | $8.41 M(+3.7%) | $32.81 M(-9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | $8.12 M(+1.1%) | $36.04 M(-10.1%) |
| Jun 2013 | - | $8.03 M(-2.7%) | $40.10 M(-14.1%) |
| Mar 2013 | - | $8.25 M(-29.2%) | $46.67 M(-14.4%) |
| Dec 2012 | $54.51 M(-32.8%) | $11.65 M(-4.4%) | $54.51 M(-16.6%) |
| Sep 2012 | - | $12.18 M(-16.6%) | $65.32 M(-11.9%) |
| Jun 2012 | - | $14.60 M(-9.3%) | $74.13 M(-6.3%) |
| Mar 2012 | - | $16.09 M(-28.4%) | $79.13 M(-2.5%) |
| Dec 2011 | $81.17 M(+9.1%) | $22.46 M(+7.0%) | $81.17 M(-1.8%) |
| Sep 2011 | - | $20.99 M(+7.1%) | $82.68 M(+2.9%) |
| Jun 2011 | - | $19.60 M(+8.2%) | $80.37 M(+3.8%) |
| Mar 2011 | - | $18.12 M(-24.4%) | $77.41 M(+4.1%) |
| Dec 2010 | $74.39 M(+20.6%) | $23.97 M(+28.3%) | $74.39 M(+6.3%) |
| Sep 2010 | - | $18.68 M(+12.3%) | $69.99 M(+4.7%) |
| Jun 2010 | - | $16.63 M(+10.1%) | $66.84 M(+4.7%) |
| Mar 2010 | - | $15.10 M(-22.9%) | $63.81 M(+3.4%) |
| Dec 2009 | $61.70 M(+21.0%) | $19.58 M(+26.1%) | $61.70 M(+7.3%) |
| Sep 2009 | - | $15.52 M(+14.1%) | $57.48 M(+5.3%) |
| Jun 2009 | - | $13.60 M(+4.7%) | $54.57 M(+4.4%) |
| Mar 2009 | - | $12.99 M(-15.4%) | $52.24 M(+2.5%) |
| Dec 2008 | $50.97 M(+53.6%) | $15.36 M(+21.8%) | $50.97 M(+14.0%) |
| Sep 2008 | - | $12.61 M(+11.8%) | $44.70 M(+10.7%) |
| Jun 2008 | - | $11.28 M(-3.7%) | $40.38 M(+7.2%) |
| Mar 2008 | - | $11.72 M(+28.9%) | $37.67 M(+13.5%) |
| Dec 2007 | $33.19 M(+51.9%) | $9.09 M(+9.6%) | $33.19 M(+3.0%) |
| Sep 2007 | - | $8.29 M(-3.2%) | $32.22 M(+11.3%) |
| Jun 2007 | - | $8.57 M(+18.5%) | $28.94 M(+18.9%) |
| Mar 2007 | - | $7.23 M(-10.9%) | $24.35 M(+11.4%) |
| Dec 2006 | $21.84 M(+152.3%) | $8.12 M(+61.9%) | $21.85 M(+59.2%) |
| Sep 2006 | - | $5.02 M(+26.2%) | $13.72 M(+21.5%) |
| Jun 2006 | - | $3.98 M(-16.0%) | $11.30 M(+54.3%) |
| Mar 2006 | - | $4.73 M(+82.7%) | $7.32 M(+182.7%) |
| Dec 2005 | $8.66 M(>+9900.0%) | - | - |
| Sep 2005 | - | $2.59 M(<-9900.0%) | $2.59 M(>+9900.0%) |
| Jun 2004 | $23.30 K(-78.8%) | -$2500.00(-113.5%) | $20.80 K(-45.3%) |
| Mar 2004 | - | $18.50 K(+285.4%) | $38.00 K(+33.3%) |
| Sep 2003 | - | $4800.00(-67.3%) | $28.50 K(-74.1%) |
| Jun 2003 | $110.10 K(+193.6%) | $14.70 K(+188.2%) | $110.10 K(+13.7%) |
| Mar 2003 | - | $5100.00(+30.8%) | $96.80 K(-3.5%) |
| Dec 2002 | - | $3900.00(-95.5%) | $100.30 K(-17.1%) |
| Sep 2002 | - | $86.40 K(+6071.4%) | $121.00 K(+222.7%) |
| Jun 2002 | $37.50 K | $1400.00(-83.7%) | $37.50 K(+3.9%) |
| Mar 2002 | - | $8600.00(-65.0%) | $36.10 K(+31.3%) |
| Dec 2001 | - | $24.60 K(+748.3%) | $27.50 K(+848.3%) |
| Sep 2001 | - | $2900.00 | $2900.00 |
FAQ
- What is China Pharma Holdings annual revenue?
- What is the all time high annual revenue for China Pharma Holdings?
- What is China Pharma Holdings annual revenue year-on-year change?
- What is China Pharma Holdings quarterly revenue?
- What is the all time high quarterly revenue for China Pharma Holdings?
- What is China Pharma Holdings quarterly revenue year-on-year change?
- What is China Pharma Holdings TTM revenue?
- What is the all time high TTM revenue for China Pharma Holdings?
- What is China Pharma Holdings TTM revenue year-on-year change?
What is China Pharma Holdings annual revenue?
The current annual revenue of CPHI is $7.01 M
What is the all time high annual revenue for China Pharma Holdings?
China Pharma Holdings all-time high annual revenue is $81.17 M
What is China Pharma Holdings annual revenue year-on-year change?
Over the past year, CPHI annual revenue has changed by -$1.09 M (-13.48%)
What is China Pharma Holdings quarterly revenue?
The current quarterly revenue of CPHI is $1.10 M
What is the all time high quarterly revenue for China Pharma Holdings?
China Pharma Holdings all-time high quarterly revenue is $23.97 M
What is China Pharma Holdings quarterly revenue year-on-year change?
Over the past year, CPHI quarterly revenue has changed by -$1.05 M (-48.82%)
What is China Pharma Holdings TTM revenue?
The current TTM revenue of CPHI is $5.54 M
What is the all time high TTM revenue for China Pharma Holdings?
China Pharma Holdings all-time high TTM revenue is $82.68 M
What is China Pharma Holdings TTM revenue year-on-year change?
Over the past year, CPHI TTM revenue has changed by -$1.47 M (-20.92%)